Journal Pre-proofs Deciphering the robustness of pyrazolo-pyridine carboxylate core structure- based compounds for inhibiting α-synuclein in Transgenic C. elegans Model of Synucleinopathy Mudasir Maqbool, Roshani Rajvansh, Kottapalli Srividya, Nasimul Hoda PII: S0968-0896(20)30470-3 DOI: https://doi.org/10.1016/j.bmc.2020.115640 Reference: BMC 115640 To appear in: Bioorganic & Medicinal Chemistry Received Date: 8 April 2020 Revised Date: 30 June 2020 Accepted Date: 4 July 2020 Please cite this article as: Maqbool, M., Rajvansh, R., Srividya, K., Hoda, N., Deciphering the robustness of pyrazolo-pyridine carboxylate core structure-based compounds for inhibiting α-synuclein in Transgenic C. elegans Model of Synucleinopathy, Bioorganic & Medicinal Chemistry (2020), doi: https://doi.org/10.1016/ j.bmc.2020.115640 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Ltd.